ABT1 modifies SMARD1 pathology via interactions with IGHMBP2 and stimulation of ATPase and helicase activity is a research paper published in JCI Insight (2022). On theSindex it has a DataRank of 0.470. It has been cited 22 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.470
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIH/NINDS
Grant: R21NS103028
Missouri Spinal Cord Injury/Disease Research Program
Grant: none
NIH
Grant: T32GM008396
Howard Hughes Medical Institute
Grant: Gilliam Fellowship
NIH/NINDS
Grant: R01NS113765
NINDS NIH HHS
Grant: R21 NS109762
National Institutes of Health
Grant: 5T32GM008396-05
MOLECULAR BASIS OF GENE EXPRESSION AND SIGNAL PROCESSING
National Institutes of Health
Grant: 5R21NS103028-02
IGHMBP2 patient-derived missense mutations: large animal models of SMARD1
National Institutes of Health
Grant: 1R21NS109762-01A1
Identification of modifiers of the neurodegenerative phenotype in nmd mice
National Institutes of Health
Grant: 5R01NS113765-03
Novel SMARD1 Mouse Models: Characterization and Evaluation of Potential Therapeutic Targets
FWCI
1.48
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals